Title : Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin.

Pub. Date : 2019 Feb

PMID : 30178570






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin. Sitagliptin Phosphate insulin Homo sapiens
2 At week 24, the between-group difference (sitagliptin - placebo) in the least squares mean (95% confidence intervals) change from baseline in HbA1c in patients using premixed insulin was -0.43% (-0.58, -0.28), P <0.001. Sitagliptin Phosphate insulin Homo sapiens